| Jeffrey Spreitzer, MD | |
|
2950 Cleveland Clinic Blvd, Weston, FL 33331-3609 | |
| (954) 659-5000 | |
| (954) 689-5118 |
| Full Name | Jeffrey Spreitzer |
|---|---|
| Gender | Male |
| Speciality | Diagnostic Radiology |
| Experience | 34 Years |
| Location | 2950 Cleveland Clinic Blvd, Weston, Florida |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1245295682 | NPI | - | NPPES |
| 250790100 | Medicaid | FL | |
| 2753088 | Medicaid | OH |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2085N0700X | Radiology - Neuroradiology | ME0060972 (Florida) | Primary |
| 2085N0700X | Radiology - Neuroradiology | 35089865 (Ohio) | Secondary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Oss Orthopaedic Hospital | York, PA | Hospital |
| Cleveland Clinic Hospital | Weston, FL | Hospital |
| Hillcrest Hospital | Mayfield heights, OH | Hospital |
| Akron General Medical Center | Akron, OH | Hospital |
| York Hospital | York, PA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Clinic Medical Services Company | 5698674653 | 274 |
| Allegiance Imaging And Radiology Llc | 3577838689 | 13 |
| Clinic Medical Services Company | 5698674653 | 274 |
| Allegiance Imaging And Radiology Llc | 3577838689 | 13 |
News Archive
Researchers and doctors at Uppsala University, along with Swedish and international collaboration partners, have found gene variants that predict the risk of a serious adverse reaction to drugs used for the treatment of hyperthyroidism. The results are published in The Lancet Diabetes & Endocrinology.
The community of bacteria that live in our intestines, also called the "gut microbiome," is important to normal intestinal function.
While authorities in Greece anxiously await test results on eight dead birds found in the northeastern Evros River delta, in another main migratory route, Croatia had also started testing dead birds found by citizens.
Regeneron Pharmaceuticals, Inc. and Sanofi today announced that the U.S. Food and Drug Administration approved Praluent (alirocumab) Injection, the first FDA-approved treatment in a new class of drugs known as PCSK9 (proprotein convertase subtilisin/kexin type 9) inhibitors.
› Verified 6 days ago
| Entity Name | The Cleveland Clinic Foundation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1679525919 PECOS PAC ID: 1850203555 Enrollment ID: O20031103000049 |
News Archive
Researchers and doctors at Uppsala University, along with Swedish and international collaboration partners, have found gene variants that predict the risk of a serious adverse reaction to drugs used for the treatment of hyperthyroidism. The results are published in The Lancet Diabetes & Endocrinology.
The community of bacteria that live in our intestines, also called the "gut microbiome," is important to normal intestinal function.
While authorities in Greece anxiously await test results on eight dead birds found in the northeastern Evros River delta, in another main migratory route, Croatia had also started testing dead birds found by citizens.
Regeneron Pharmaceuticals, Inc. and Sanofi today announced that the U.S. Food and Drug Administration approved Praluent (alirocumab) Injection, the first FDA-approved treatment in a new class of drugs known as PCSK9 (proprotein convertase subtilisin/kexin type 9) inhibitors.
› Verified 6 days ago
| Entity Name | Wooster Clinic Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1033135009 PECOS PAC ID: 6800708124 Enrollment ID: O20031211000578 |
News Archive
Researchers and doctors at Uppsala University, along with Swedish and international collaboration partners, have found gene variants that predict the risk of a serious adverse reaction to drugs used for the treatment of hyperthyroidism. The results are published in The Lancet Diabetes & Endocrinology.
The community of bacteria that live in our intestines, also called the "gut microbiome," is important to normal intestinal function.
While authorities in Greece anxiously await test results on eight dead birds found in the northeastern Evros River delta, in another main migratory route, Croatia had also started testing dead birds found by citizens.
Regeneron Pharmaceuticals, Inc. and Sanofi today announced that the U.S. Food and Drug Administration approved Praluent (alirocumab) Injection, the first FDA-approved treatment in a new class of drugs known as PCSK9 (proprotein convertase subtilisin/kexin type 9) inhibitors.
› Verified 6 days ago
| Entity Name | Clinic Medical Services Company |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1528013984 PECOS PAC ID: 5698674653 Enrollment ID: O20040108000271 |
News Archive
Researchers and doctors at Uppsala University, along with Swedish and international collaboration partners, have found gene variants that predict the risk of a serious adverse reaction to drugs used for the treatment of hyperthyroidism. The results are published in The Lancet Diabetes & Endocrinology.
The community of bacteria that live in our intestines, also called the "gut microbiome," is important to normal intestinal function.
While authorities in Greece anxiously await test results on eight dead birds found in the northeastern Evros River delta, in another main migratory route, Croatia had also started testing dead birds found by citizens.
Regeneron Pharmaceuticals, Inc. and Sanofi today announced that the U.S. Food and Drug Administration approved Praluent (alirocumab) Injection, the first FDA-approved treatment in a new class of drugs known as PCSK9 (proprotein convertase subtilisin/kexin type 9) inhibitors.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Jeffrey Spreitzer, MD 2950 Cleveland Clinic Blvd, Weston, FL 33331-3609 Ph: (954) 659-5000 | Jeffrey Spreitzer, MD 2950 Cleveland Clinic Blvd, Weston, FL 33331-3609 Ph: (954) 659-5000 |
News Archive
Researchers and doctors at Uppsala University, along with Swedish and international collaboration partners, have found gene variants that predict the risk of a serious adverse reaction to drugs used for the treatment of hyperthyroidism. The results are published in The Lancet Diabetes & Endocrinology.
The community of bacteria that live in our intestines, also called the "gut microbiome," is important to normal intestinal function.
While authorities in Greece anxiously await test results on eight dead birds found in the northeastern Evros River delta, in another main migratory route, Croatia had also started testing dead birds found by citizens.
Regeneron Pharmaceuticals, Inc. and Sanofi today announced that the U.S. Food and Drug Administration approved Praluent (alirocumab) Injection, the first FDA-approved treatment in a new class of drugs known as PCSK9 (proprotein convertase subtilisin/kexin type 9) inhibitors.
› Verified 6 days ago
Jose Irizarry, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 2950 Cleveland Clinic Blvd, Weston, FL 33331 Phone: 954-659-5000 Fax: 659-659-6039 | |
Rodolfo J Blandon, MD, MBA Radiology Medicare: Accepting Medicare Assignments Practice Location: 2950 Cleveland Clinic Blvd, Weston, FL 33331 Phone: 954-659-5000 Fax: 954-689-5118 | |
Dr. Bradley John Potsic, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 2950 Cleveland Clinic Blvd, Weston, FL 33331 Phone: 954-689-5123 Fax: 954-689-5115 | |
Eva Marie Suarez, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 2950 Cleveland Clinic Blvd, Weston, FL 33331 Phone: 954-659-5840 | |
Christopher Tournade, MD Radiology Medicare: Medicare Enrolled Practice Location: 2950 Cleveland Clinic Blvd, Weston, FL 33331 Phone: 954-659-5000 | |
Ian Ross Drexler, M.D., M.B.A. Radiology Medicare: Accepting Medicare Assignments Practice Location: 2950 Cleveland Clinic Blvd, Weston, FL 33331 Phone: 954-659-5000 |